16-11742638-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015914.7(TXNDC11):āc.93C>Gā(p.Asp31Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000535 in 1,307,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015914.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNDC11 | NM_015914.7 | c.93C>G | p.Asp31Glu | missense_variant | 1/12 | ENST00000283033.10 | NP_056998.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNDC11 | ENST00000283033.10 | c.93C>G | p.Asp31Glu | missense_variant | 1/12 | 2 | NM_015914.7 | ENSP00000283033 | P2 | |
TXNDC11 | ENST00000356957.7 | c.93C>G | p.Asp31Glu | missense_variant | 1/13 | 1 | ENSP00000349439 | A2 | ||
TXNDC11-AS1 | ENST00000572811.1 | n.729G>C | non_coding_transcript_exon_variant | 1/1 | ||||||
TXNDC11 | ENST00000573174.1 | n.157C>G | non_coding_transcript_exon_variant | 1/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000535 AC: 7AN: 1307576Hom.: 0 Cov.: 35 AF XY: 0.00000621 AC XY: 4AN XY: 643768
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.93C>G (p.D31E) alteration is located in exon 1 (coding exon 1) of the TXNDC11 gene. This alteration results from a C to G substitution at nucleotide position 93, causing the aspartic acid (D) at amino acid position 31 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at